Dr. Michael Cotant, a urologist with McLaren Central Michigan, has achieved a career milestone shared by only a handful of other physicians in the multistate Great Lakes Region, having performed his 500th UroLift procedure, addressing benign prostatic hyperplasia (BPH), a common, quality-of-life-limiting condition.
BPH is a noncancerous enlargement of the prostate gland affecting more than half of men aged 50 and over, leading to increased pressure on the urethra, resulting in complications during urination, such as frequently needing to go, difficulty starting and stopping, and a weak stream among others.
The UroLift System is a minimally invasive, common outpatient procedure to relieve patients of their symptoms while preserving the prostate.
“Reaching 500 UroLifts is a meaningful moment, with each one of those cases represents a patient’s trust, something for which I am truly honored and grateful,” Dr. Cotant said. “This achievement has been made possible by the incredible and talented teams I have had the privilege to work over these years.”
Dr. Cotant is only the seventh physician in the Great Lakes Region (encompassing Michigan, Ohio, and Indiana) to reach the 500-procedure milestone, and he is among the top 3 percent of physicians currently performing the procedure.
“Dr. Cotant reaching such a significant milestone reflects not only his expertise in this procedure, but also a deep commitment to improve the quality of life for his patients,” said Robert David, McLaren Central Michigan President and CEO. “Our team shares a collective pride in Dr. Cotant, his team, and their dedication to the care of their patients.”
An endoscopic procedure, the UroLift System is placed in the urethra and guided to the area obstructed by the enlarged prostate. The obstructive tissue is moved aside, and implants are deployed to hold the prostate in its new, unobstructive position.
Dr. Cotant performed his first UroLift in 2015, not long after the procedure received FDA approval. After joining McLaren Central Michigan in September 2024, he has maintained his proficiency and aptitude with the procedure, performing 82 UroLifts in his time with the hospital to reach 500.
Learn more about all services available at McLaren Central Michigan at mclaren.org/centralmichigan.
About McLaren Central Michigan
McLaren Central Michigan is a 118-bed acute care hospital located in Mount Pleasant, Michigan, serving all of Isabella County. Part of statewide McLaren Health Care, McLaren Central Michigan provides a range of patient-centered care offerings, including primary, preventive, and diagnostic services, emergency medicine, and specialty care, including surgical services and orthopedics. A branch of the Karmanos Cancer Network, the largest network of cancer providers in the state, cancer care provided at the Karmanos Cancer Institute at McLaren Central Michigan is anchored by the world-renowned Karmanos Cancer Institute in Detroit. McLaren Central Michigan is accredited by The Joint Commission and is recognized as an accessible and dependable source of high-quality health care throughout the region. Learn more at mclaren.org/centralmichigan.
About McLaren Health Care
McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $7.3 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 12 hospitals in Michigan, ambulatory surgery centers, imaging centers, a 640-member employed primary and specialty care physician network, commercial and Medicaid HMOs covering more than 732,838 lives in Michigan and Indiana, home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan’s largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, a National Cancer Institute-designated comprehensive cancer center. McLaren has 28,000 full-, part-time and contracted employees and more than 113,000 network providers throughout Michigan, Indiana, and Ohio. Learn more at mclaren.org.